BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1402 related articles for article (PubMed ID: 15328326)

  • 21. The phenotype of
    Niemeijer ND; Rijken JA; Eijkelenkamp K; van der Horst-Schrivers ANA; Kerstens MN; Tops CMJ; van Berkel A; Timmers HJLM; Kunst HPM; Leemans CR; Bisschop PH; Dreijerink KMA; van Dooren MF; Bayley JP; Pereira AM; Jansen JC; Hes FJ; Hensen EF; Corssmit EPM
    Eur J Endocrinol; 2017 Aug; 177(2):115-125. PubMed ID: 28490599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Germline mutations and genotype-phenotype correlation in Asian Indian patients with pheochromocytoma and paraganglioma.
    Pandit R; Khadilkar K; Sarathi V; Kasaliwal R; Goroshi M; Khare S; Nair S; Raghavan V; Dalvi A; Hira P; Fernandes G; Sathe P; Rojekar A; Malhotra G; Bakshi G; Prakash G; Bhansali A; Walia R; Kamalanathan S; Sahoo J; Desai A; Bhagwat N; Mappa P; Rajput R; Chandrashekhar SR; Shivane V; Menon P; Lila A; Bandgar T; Shah N
    Eur J Endocrinol; 2016 Oct; 175(4):311-23. PubMed ID: 27539324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Higher risk of phaeochromocytoma/paraganglioma (Phaeo-Pgl) in SDHD than SDHB carriers: an Australian cohort study.
    Hong A; Shanahan M; Schenberg T; Inder W; MacIsaac R; James P; Sachithanandan N
    Intern Med J; 2019 Apr; 49(4):529-532. PubMed ID: 30957378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing.
    Brouwers FM; Eisenhofer G; Tao JJ; Kant JA; Adams KT; Linehan WM; Pacak K
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4505-9. PubMed ID: 16912137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutation analysis of the SDHB and SDHD genes in pheochromocytomas and paragangliomas: identification of a novel nonsense mutation (Q168X) in the SDHB gene.
    Oishi Y; Nagai S; Yoshida M; Fujisawa S; Sazawa A; Shinohara N; Nonomura K; Matsuno K; Shimizu C
    Endocr J; 2010; 57(8):745-50. PubMed ID: 20505258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High frequency of germline succinate dehydrogenase mutations in sporadic cervical paragangliomas in northern Spain: mitochondrial succinate dehydrogenase structure-function relationships and clinical-pathological correlations.
    Lima J; Feijão T; Ferreira da Silva A; Pereira-Castro I; Fernandez-Ballester G; Máximo V; Herrero A; Serrano L; Sobrinho-Simões M; Garcia-Rostan G
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4853-64. PubMed ID: 17848412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High prevalence of SDHB mutations in head and neck paraganglioma in Belgium.
    Persu A; Hamoir M; Grégoire V; Garin P; Duvivier E; Reychler H; Chantrain G; Mortier G; Mourad M; Maiter D; Vikkula M
    J Hypertens; 2008 Jul; 26(7):1395-401. PubMed ID: 18551016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No difference in phenotype of the main Dutch SDHD founder mutations.
    van Hulsteijn LT; den Dulk AC; Hes FJ; Bayley JP; Jansen JC; Corssmit EP
    Clin Endocrinol (Oxf); 2013 Dec; 79(6):824-31. PubMed ID: 23586964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening of mutations in genes that predispose to hereditary paragangliomas and pheochromocytomas.
    Lefebvre S; Borson-Chazot F; Boutry-Kryza N; Wion N; Schillo F; Peix JL; Brunaud L; Finat A; Calender A; Giraud S
    Horm Metab Res; 2012 May; 44(5):334-8. PubMed ID: 22517554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial pheochromocytoma.
    Erlic Z; Neumann HP
    Hormones (Athens); 2009; 8(1):29-38. PubMed ID: 19269919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variant type is associated with disease characteristics in SDHB, SDHC and SDHD-linked phaeochromocytoma-paraganglioma.
    Bayley JP; Bausch B; Rijken JA; van Hulsteijn LT; Jansen JC; Ascher D; Pires DEV; Hes FJ; Hensen EF; Corssmit EPM; Devilee P; Neumann HPH
    J Med Genet; 2020 Feb; 57(2):96-103. PubMed ID: 31492822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas.
    Burnichon N; Rohmer V; Amar L; Herman P; Leboulleux S; Darrouzet V; Niccoli P; Gaillard D; Chabrier G; Chabolle F; Coupier I; Thieblot P; Lecomte P; Bertherat J; Wion-Barbot N; Murat A; Venisse A; Plouin PF; Jeunemaitre X; Gimenez-Roqueplo AP;
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2817-27. PubMed ID: 19454582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of three new variants of SDHx genes in a cohort of Portuguese patients with extra-adrenal paragangliomas.
    Domingues R; Montalvão P; Magalhães M; Santos R; Duarte L; Bugalho MJ
    J Endocrinol Invest; 2012 Dec; 35(11):975-80. PubMed ID: 22293219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas.
    Timmers HJ; Kozupa A; Eisenhofer G; Raygada M; Adams KT; Solis D; Lenders JW; Pacak K
    J Clin Endocrinol Metab; 2007 Mar; 92(3):779-86. PubMed ID: 17200167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gross SDHB deletions in patients with paraganglioma detected by multiplex PCR: a possible hot spot?
    Cascón A; Montero-Conde C; Ruiz-Llorente S; Mercadillo F; Letón R; Rodríguez-Antona C; Martínez-Delgado B; Delgado M; Díez A; Rovira A; Díaz JA; Robledo M
    Genes Chromosomes Cancer; 2006 Mar; 45(3):213-9. PubMed ID: 16258955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High prevalence of founder mutations of the succinate dehydrogenase genes in the Netherlands.
    Hensen EF; van Duinen N; Jansen JC; Corssmit EP; Tops CM; Romijn JA; Vriends AH; van der Mey AG; Cornelisse CJ; Devilee P; Bayley JP
    Clin Genet; 2012 Mar; 81(3):284-8. PubMed ID: 21348866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imaging work-up for screening of paraganglioma and pheochromocytoma in SDHx mutation carriers: a multicenter prospective study from the PGL.EVA Investigators.
    Gimenez-Roqueplo AP; Caumont-Prim A; Houzard C; Hignette C; Hernigou A; Halimi P; Niccoli P; Leboulleux S; Amar L; Borson-Chazot F; Cardot-Bauters C; Delemer B; Chabolle F; Coupier I; Libé R; Peitzsch M; Peyrard S; Tenenbaum F; Plouin PF; Chatellier G; Rohmer V
    J Clin Endocrinol Metab; 2013 Jan; 98(1):E162-73. PubMed ID: 23162105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Succinate dehydrogenase-deficient tumors: diagnostic advances and clinical implications.
    Barletta JA; Hornick JL
    Adv Anat Pathol; 2012 Jul; 19(4):193-203. PubMed ID: 22692282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of screening kindreds for SDHD p.Cys11X as a common mutation associated with paraganglioma syndrome type 1.
    Peczkowska M; Erlic Z; Hoffmann MM; Furmanek M; Cwikla J; Kubaszek A; Prejbisz A; Szutkowski Z; Kawecki A; Chojnowski K; Lewczuk A; Litwin M; Szyfter W; Walter MA; Sullivan M; Eng C; Januszewicz A; Neumann HP
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4818-25. PubMed ID: 18826997
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 71.